市場調査レポート - 229027

医療アプリケーションにおけるナノテクノロジーの世界市場

Nanotechnology in Medical Applications: The Global Market

発行 BCC Research
出版日 ページ情報 英文 187 Pages
価格
医療アプリケーションにおけるナノテクノロジーの世界市場 Nanotechnology in Medical Applications: The Global Market
出版日: 2012年01月19日 ページ情報: 英文 187 Pages

世界のナノメディスン市場は2010年に638億米ドル、2011年に728億米ドルとなりました。同市場は2011年から2016年の間、年複利成長率(CAGR)12.5%で拡大し、2016年には1309億米ドルへと成長する見通しです。

当レポートでは、ナノテクノロジー特性を組み込んだ医薬品(ナノメディスン)の世界市場について調査し、市場、技術、市場動向、製品カテゴリーおよび主要国市場別の販売予測(〜2016年)を分析しており、主なナノメディスン企業のプロファイルを盛り込んで、概略以下の構成でお届けします。

第1章 イントロダクション

第2章 サマリー

第3章 概要

  • 医療ナノテクノロジー:ナノメディスン
  • 将来の可能性
  • 市場潜在性
  • ナノテクノロジーについて
  • 多くのナノテクノロジーの利用
  • ナノテクノロジーのツール
  • ナノテクノロジーのリスク
  • 市場におけるナノテクノロジー

第4章 ナノメディスン

  • ナノ医療技術の開発
  • ナノメディスンの治療への利用
  • リスク因子

第5章 ナノメディスン市場

  • 市場促進因子
  • 市場見通し・予測
  • 世界のナノメディスン市場
  • 主な製品カテゴリー

第6章 ナノメディスン産業:企業プロファイル

第7章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

Abstract

REPORT HIGHLIGHTS

  • The global nanomedicine market reached $63.8 billion in 2010 and $72.8 billion in 2011. The market is expected to grow to $130.9 billion by 2016 at a compound annual growth rate (CAGR) of 12.5% between years 2011 and 2016.
  • The central nervous system (CNS) products market reached $11.7 billion in 2010 and $14.0 billion in 2011. It is expected to grow to $29.5 billion by 2016, a CAGR of 16.1% between years 2011 and 2016.
  • The anticancer products market reached $25.2 billion in 2010 and $28.0 billion in 2011. It is expected to reach $46.7 billion by 2016, a CAGR of 10.8% between years 2011 and 2016.

SUMMARY FIGURE
NANOMEDICAL GLOBAL SALES BY THERAPEUTIC AREA, 2009-2016
($ BILLIONS)

Source: BCC Research

STUDY GOALS AND OBJECTIVES

The aim of this report is to provide detailed market, technology and industry analyses to help readers quantify and qualify the market for prescription drug products incorporating nanotechnology features. Important trends are identified and sales forecasts by product categories and major country markets are provided through 2016; these are based on industry sources and considered assessment of the regulatory environment, healthcare policies, demographics, and other factors that directly affect the nanomedicine-related drug market. The wider economic environment is also taken into account.

The report examines strategies employed by companies specializing in nanomedicine to meet the challenges of this highly competitive market.

REASONS FOR DOING THE STUDY

Nanomedicine is already an established market. Unlike some other potential applications of nanotechnology, which are still largely experimental, nanomedicine has already produced a number of significant products in which the nano dimension has made a significant contribution to product effectiveness. Now that aspects of the nanomedicine market are established, it is appropriate to review the technology, see its practical applications so far, evaluate the participating companies and look to its future.

SCOPE OF REPORT

This report discusses the implications of technology and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global terms and analyzed by the most important national markets. The important technologies supporting nanomedicine are reviewed, and the nature and structure of the nanomedicine industry is discussed with profiles of the leading 60+ companies, including recent M&A activity. Five-year sales forecasts are provided for the national markets and the major therapeutic categories of products involved.

MARKET ANALYSES AND FORECASTS

Market figures are based on revenues at the manufacturer level and are projected at 2011-dollar value without attempting to predict the effect of inflation/deflation.

Therapeutic categories quantified and forecast include cancer, CNS diseases, infections and cardiovascular. Country markets analyzed are the U.S., Japan, Germany, France, UK, Italy, and Spain.

METHODOLOGY

Primary research includes interviews with leading individuals in nanomedicine companies and industry associations. Primary sources of published data include company annual reports, SEC filings, and government and industry publications. Secondary sources consist of literature searches, industry journals and other commercial publications. Data for market estimates and forecasts are pooled from a range of sources, critically assessed by BCC.

INFORMATION SOURCES

Sources of information included marketing strategists, industry executives, government agencies and regulatory bodies, and surveys of physicians and pharmacists. Company annual reports and SEC filings, journal articles, and data from healthcare institutions were also mined, as well as publications of relevant trade associations.

ANALYST CREDENTIALS

Paul Evers has been involved in analyzing pharmaceutical and medical markets for 20 years. He is the author of previous reports on the nanomedicine marketplace as well as analyses of major therapeutic categories and the pharmaceutical regulatory environment.

Table of Contents

Nanotechnology in Medical Applications: The Global Market

Chapter - 1: INTRODUCTION - Complimentary

  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR DOING THE STUDY
  • SCOPE OF REPORT
  • MARKET ANALYSES AND FORECASTS
  • METHODOLOGY
  • INTENDED AUDIENCE
  • INFORMATION SOURCES
  • ANALYST CREDENTIALS
  • RELATED BCC REPORTS
  • BCC ON-LINE SERVICES
  • DISCLAIMER

Chapter - 2: SUMMARY

  • DEFINITION
  • RESEARCH AND COMMERCIALIZATION
  • APPLICATIONS
  • MARKET

Chapter - 3: OVERVIEW

  • MEDICAL NANOTECHNOLOGY: NANOMEDICINE
  • FUTURE POSSIBILITIES
  • MARKET POTENTIAL
  • ABOUT NANOTECHNOLOGY
  • THE MANY USES OF NANOTECHNOLOGY
  • THE TOOLS OF NANOTECHNOLOGY
  • RISKS OF NANOTECHNOLOGY
  • NANOTECHNOLOGY IN THE MARKETPLACE

Chapter - 4: NANOMEDICINE

  • DEVELOPMENT OF NANOMEDICAL TECHNOLOGIES
  • THERAPEUTIC USES OF NANOMEDICINE
  • THE RISK FACTOR
    • Table 1: NANOMEDICINE TIMESCALE
    • Table 2: MAIN NANOTECHNOLOGIES USED IN MEDICINE, WITH APPLICATIONS

Chapter - 5: MARKETS FOR NANOMEDICINE

  • MARKET DRIVERS
  • MARKET ESTIMATES AND FORECASTS
  • GLOBAL NANOMEDICINE MARKET
  • MAIN PRODUCT CATEGORIES

Chapter - 6: THE NANOMEDICINE INDUSTRY

  • ABLYNX
  • ABRAXIS BIOSCIENCE
  • ACCESS
  • ACRYMED INC.
  • ACUSPHERE
  • ADVANCED MAGNETICS
  • ALLTRACELL
  • ALPHARX INC.
  • ANSON NANO-BIOTECHNOLOGY (ZHUHAI) CO. LTD
  • APHIOS CORP.
  • BIOCRYSTAL LTD
  • BIOFORCE NANOSCIENCES
  • BIO-GATE
  • BIOPHAGE PHARMA
  • BIOPHAN TECHNOLOGIES
  • BIOSANTE PHARMACEUTICALS INC.
  • CALANDO PHARMACEUTICALS
  • CAMURUS AB
  • CAPSULUTION PHARMA AG
  • COMBIMATRIX CORPORATION
  • DAMAGE PREVENTION CONCEPT
  • ELAN DRUG TECHNOLOGIES
  • ENZON PHARMACEUTICALS, INC.
  • FARFIELD SCIENTIFIC
  • GE HEALTHCARE LIFE SCIENCES
  • GILEAD
  • HEALTHPLUS INTERNATIONAL INC.
  • IGI INC.
  • JR NANOTECH, PLC
  • KEREOS, INC.
  • KEYSTONE NANO, INC.
  • KLEINDIEK NANOTECHNIK GMBH
  • LABOPHARM INC.
  • LIPLASOME PHARMA A/S
  • LUMERA CORPORATION
  • MAGFORCE NANOTECHNOLOGIES AG
  • MAGNAMEDICS GMBH
  • MICROFLUIDICS INTERNATIONAL CORPORATION
  • MIV THERAPEUTICS INC.
  • MOLECULAR PROFILES
  • NANOBIO CORPORATION
  • NANOBIOTIX
  • NANOCARRIER CO LTD
  • NANOCYTE INC
  • NANOGEN INC
  • NANOINK, INC.
  • NANOLOGIX, INC.
  • NANOMED PHARMACEUTICALS, INC.
  • NANOMIX INC
  • NANOPHARM AG
  • NANOSPECTRA BIOSCIENCES, INC.
  • NANOSPHERE, INC.
  • NANOSTRUCTURES, INC.
  • NANOSYN INC
  • NANOTHERAPEUTICS, INC.
  • NANOTROPE INC.
  • NANOVIRICIDES INC
  • NUCRYST PHARMACEUTICALS
  • NUTRALEASE
  • ORTHOVITA INC.
  • PIONEER SURGICAL TECHNOLOGY
  • PSIVIDA LTD
  • QIAGEN N.V.
  • SKYEPHARMA PLC
  • SOLUBEST
  • STARPHARMA HOLDINGS LTD
  • TECAN GROUP LTD.
  • TELOMOLECULAR CORPORATION

Chapter - 7: APPENDIX

  • Table 27: GLOSSARY

List of Tables

  • Summary Table: NANOMEDICAL GLOBAL SALES BY THERAPEUTIC AREA, THROUGH 2016
  • Table 1: NANOMEDICINE TIMESCALE
  • Table 2: MAIN NANOTECHNOLOGIES USED IN MEDICINE, WITH APPLICATIONS
  • Table 3: MARKETED LIPOSOME NANOPHARMACEUTICALS
  • Table 4: NANOCRYSTAL PHARMACEUTICALS
  • Table 5: MARKETED AND DEVELOPMENTAL PRODUCTS IN MICELLE FORM
  • Table 6: MARKETED PRODUCTS WITH NANO-ENHANCED DELIVERY
  • Table 7: EUROPEAN NANOCENTRES
  • Table 8: MARKETED NANOPHARMACEUTICALS
  • Table 9: MARKETED NANO-IMAGING, DIAGNOSTICS, BIOMATERIALS
  • Table 10: SHARE OF NANOTECHNOLOGY REVENUES BY INDUSTRY SECTOR, 2010
  • Table 11: GLOBAL NANOMEDICINE MARKET, THROUGH 2016
  • Table 12: MAJOR MARKETED ANTICANCER NANOPHARMACEUTICALS, 2010
  • Table 13: MARKET FORECAST FOR CANCER NANOTHERAPEUTICS AND NANODIAGNOSTICS, THROUGH 2016
  • Table 14: MAJOR MARKETED CNS NANOPHARMACEUTICALS, 2010
  • Table 15: MARKET FORECAST FOR CNS NANOMEDICINES, THROUGH 2016
  • Table 16: MAJOR MARKETED ANTI-INFECTIVE NANOPHARMACEUTICALS, 2010
  • Table 17: MARKET FORECAST FOR ANTI-INFECTION NANOTHERAPEUTICS AND NANODIAGNOSTICS, THROUGH 2016
  • Table 18: MAJOR MARKETED NANOMEDICINES FOR CARDIOVASCULAR AND AUTO-INFLAMMATORY DISEASES, 2010
  • Table 19: MARKETS FOR CARDIOVASCULAR AND ANTI-INFLAMMATORY NANOPRODUCTS, THROUGH 2016
  • Table 20: U.S. NANOMEDICINE MARKET, THROUGH 2016
  • Table 21: NANOMEDICINE MARKET IN JAPAN, THROUGH 2016
  • Table 22: NANOMEDICINE MARKET IN GERMANY, THROUGH 2016
  • Table 23: NANOMEDICINE MARKET IN FRANCE, THROUGH 2016
  • Table 24: NANOMEDICINE MARKET IN UNITED KINGDOM, THROUGH 2016
  • Table 25: NANOMEDICINE MARKET IN ITALY, THROUGH 2016
  • Table 26: NANOMEDICINE MARKET IN SPAIN, THROUGH 2016
  • Table 27: GLOSSARY

List of Figures

  • Summary Figure: NANOMEDICAL GLOBAL SALES BY THERAPEUTIC AREA, 2009-2016

医療アプリケーションにおけるナノテクノロジーの世界市場」は2012年01月19日にBCCリサーチより発行されました。 当レポートは187 Pagesで構成され、税抜¥566,037より販売しています。

Back to Top